A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01674361
Recruitment Status : Completed
First Posted : August 28, 2012
Last Update Posted : August 2, 2017
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 30, 2015
  Actual Study Completion Date : April 30, 2015
  Certification/Extension First Submitted : September 10, 2013